Candel Therapeutics, Inc. · NASDAQ:CADL
Candel Therapeutics, Inc. shareholders
As of Sep 30, 2026, 137 institutions reported holding Candel Therapeutics, Inc., 64.9% of its shares. Largest: Fidelity, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Candel Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 11.6M | 14.7% | +580K | Nov 10, 2026 |
| BlackRock | 5.18M | 6.6% | +214K | Nov 13, 2026 |
| Vanguard | 4.02M | 5.1% | +442K | Nov 13, 2026 |
| State Street | 3.81M | 4.9% | +257K | Nov 12, 2026 |
| Portolan Capital Management, LLC | 3.54M | 4.5% | +48,163 | Nov 16, 2026 |
| Acorn Capital Advisors, LLC | 3.5M | 4.5% | no change | Nov 16, 2026 |
| Saturn V Capital Management LP | 3.48M | 4.4% | +173K | Nov 16, 2026 |
| Rtw Investments, LP | 3.21M | 4.1% | −3.21M | Nov 16, 2026 |
| Geode Capital | 1.71M | 2.2% | +135K | Nov 6, 2026 |
| Millennium | 971K | 1.2% | −123K | Nov 16, 2026 |